PROM1 and glioma: In the experiment of co‐culturing glioma stem cells with CAR‐T cells, Zhu et al. proved that anti‐CD133 CAR‐T cells can kill tumour patients‐derived glioma stem cells in vitro and have also shown therapeutic effects in animal models of orthotopic tumours.50